-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A999191 | Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2), Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2), |
|||
| A999192 | Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 ), Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 ), |
|||
| A666747 | Anti-TNF-alpha Reference Antibody (Ozoralizumab), Target:TNF-alpha,Uniprot:P01375,Species:Human,isotype:VHH-VHH-VHH Anti-TNF-alpha Reference Antibody (Ozoralizumab), Target:TNF-alpha,Uniprot:P01375,Species:Human,isotype:VHH-VHH-VHH |
|||
| A666772 | Anti-TNFalpha & IL17 Reference Antibody (Remtolumab), Target:IL-17&TNF-alpha,Uniprot:P01375&Q16552-1,Species:Human,isotype:DVD-Ig Anti-TNFalpha & IL17 Reference Antibody (Remtolumab), Target:IL-17&TNF-alpha,Uniprot:P01375&Q16552-1,Species:Human,isotype:DVD-Ig |
|||
| A999193 | Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab), Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab), |
|||
| A999194 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab), |
|||
| A999195 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab), |
|||
| A999196 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab), |
|||
| A999197 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab), |
|||
| A999198 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab), |
|||
| A999199 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab), |
|||
| A999200 | Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab), Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab), |
|||
| A999201 | Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), |
|||
| A999202 | Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), |
|||
| A999203 | Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), |
|||
| A999204 | Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab), Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab), |
|||
| A999205 | Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21), Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21), |
|||
| A999206 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178), |
|||
| A999207 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab), |
|||
| A999208 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab), |
